Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ESH Hospitality, Inc.NONE · Entity 16193 | Director | June 16, 2021 | June 21, 2021 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | September 30, 2026 | October 02, 2026 |
| OMEGA HEALTHCARE INVESTORS INCOHI · Entity 3362 | Director | June 05, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ESH Hospitality, Inc.
Report date June 16, 2021 · Filed June 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Paired SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-06-16 · Disposition to issuer · Disposed 41,001 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F2: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. |
| Paired SharesSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2021-06-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-06-16 · Disposition to issuer · Disposed 1,500 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F2: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F3: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021.
F2: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.
F3: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.
Elanco Animal Health Inc
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,721.5916 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 642.0277 · Balance 10,721.5916 F1: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
F2: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
F3: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026.
OMEGA HEALTHCARE INVESTORS INC
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 44,992 |
Reported balance
After 2026-06-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 6,205 · Balance 44,992 F1: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date"). F3: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan. F4: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units.
F2: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date").
F3: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan.
F4: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Extended Stay America, Inc.
Report date June 16, 2021 · Filed June 17, 2021
Section 16 reporting ended · disclosed 2021-06-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Paired SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-06-16 · Sale · Disposed 41,001 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. |
| Paired SharesSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2021-06-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-06-16 · Sale · Disposed 1,500 · Balance 0 F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F3: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit.
F2: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger.
F3: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 00:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 642.0277 | $22.39 | $14,375.00 |
DisclosureSEC source: 0001679166-26-000013 · form4-10012026_081007.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,721.5916 Underlying: Common Stock · 642.0277 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on September 30, 2026. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 584.1121 | $24.61 | $14,375.00 |
DisclosureSEC source: 0001679166-26-000011 · form4-07022026_080714.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,079.5639 Underlying: Common Stock · 584.1121 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on June 30, 2026. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $24.61 on June 30, 2026. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:15 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 6,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001679166-26-000008 · form4-06092026_040624.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,992 Underlying: Common Stock · 6,205 shares Expires not disclosed F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · derivative.exercise_price: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2027 Annual Meeting of Shareholders (the "Vesting Date"). F3 · derivative.exercise_date: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan. F4 · derivative.expiration_date: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:43 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 12,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001679166-26-000006 · form4-05262026_080551.xml · nonDerivative · entry 2 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,847 F2 · shares: Grant of restricted stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:43 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 4,678 | $0.00 | $0.00 |
DisclosureSEC source: 0001679166-26-000006 · form4-05262026_080551.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,651 F1 · shares: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:02 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 600.7104 | $23.93 | $14,375.00 |
DisclosureSEC source: 0001679166-26-000004 · form4-04022026_080421.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,495.4518 Underlying: Common Stock · 600.7104 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.93 on March 31, 2026. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $23.93 on March 31, 2026. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:35 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 381.1312 | $22.63 | $8,625.00 |
DisclosureSEC source: 0001679166-26-000002 · form4-01052026_100159.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,894.7414 Underlying: Common Stock · 381.1312 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $22.63 on December 31, 2025. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $22.63 on December 31, 2025. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 22:12 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 10,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001679166-25-000007 · form4-12022025_101219.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,973 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 21:20 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 428.2522 | $20.14 | $8,625.00 |
DisclosureSEC source: 0001679166-25-000005 · form4-10022025_091028.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,513.6102 Underlying: Common Stock · 428.2522 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.14 on September 30, 2025. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $20.14 on September 30, 2025. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 603.9916 | $14.28 | $8,625.00 |
DisclosureSEC source: 0001415889-25-019033 · form4-07022025_080721.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,085.358 Underlying: Common Stock · 603.9916 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.28 on June 30, 2025. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.28 on June 30, 2025. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:05 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 6,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-016462 · form4-06102025_040615.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,405 Underlying: Common Stock · 6,150 shares Expires not disclosed F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · derivative.exercise_price: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2026 Annual Meeting of Shareholders (the "Vesting Date"). F3 · derivative.exercise_date: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan. F4 · derivative.expiration_date: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:41 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 821.4286 | $10.50 | $8,625.00 |
DisclosureSEC source: 0001415889-25-009744 · form4-04022025_090439.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,481.3664 Underlying: Common Stock · 821.4286 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.50 on March 31, 2025. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.50 on March 31, 2025. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:11 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-028151 · form4-12032024_101223.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,659 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 19:54 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 5,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016332 · form4-06112024_070654.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,772 Underlying: Common Stock · 5,756 shares Expires not disclosed F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · derivative.exercise_price: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2025 Annual Meeting of Shareholders. (the "Vesting Date"). F3 · derivative.exercise_date: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan. F4 · derivative.expiration_date: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 21:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 964.7651 | $14.90 | $14,375.00 |
DisclosureSEC source: 0001415889-24-000323 · form4-01032024_090123.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,659.9378 Underlying: Common Stock · 964.7651 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $14.90 on December 29, 2023. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 22:34 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 20,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-015783 · form4-12042023_101211.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,490 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 20:40 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 1,278.9146 | $11.24 | $14,375.00 |
DisclosureSEC source: 0001415889-23-013887 · form4-10032023_081002.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,695.1727 Underlying: Common Stock · 1,278.9146 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $11.24 on September 29, 2023. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:12 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 1,428.9264 | $10.06 | $14,375.00 |
DisclosureSEC source: 0001415889-23-010788 · form4-07052023_090706.xml · derivative · entry 2 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,416.2581 Underlying: Common Stock · 1,428.9264 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $10.06 on June 30, 2023. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:35 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 7,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009389 · form4-06072023_090608.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,721 Underlying: Common Stock · 7,076 shares Expires not disclosed F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · derivative.exercise_price: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted to transfer and sale until Omega's 2024 Annual Meeting of Shareholders. (the "Vesting Date"). F3 · derivative.exercise_date: These units are restricted from sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all defined in such plan. F4 · derivative.expiration_date: These units do not expire and will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F5 · balance_after: Includes deferred shares acquired via dividend reinvestment. Read SEC document |
| March 31, 2023 Filed Jul 5, 2023 21:12 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 1,529.2553 | $9.40 | $14,375.00 |
DisclosureSEC source: 0001415889-23-010788 · form4-07052023_090706.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,987.3317 Underlying: Common Stock · 1,529.2553 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $9.40 on March 31, 2023. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 22:06 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 18,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-011974 · form4-12022022_101211.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,116 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 18:43 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 9,237 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006194 · form4-06072022_110645.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,021 Underlying: Common Stock · 9,237 shares Expires not disclosed F1 · derivative.exercise_price: Units convert into shares of common stock on a one-to-one basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · shares: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted as to transfer and sale until Omega's 2023 Annual Meeting of Shareholders (the "Vesting Date"). F3 · derivative.exercise_date: These units are restricted as to sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F4 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:05 UTC | Elanco Animal Health Inc TNC · Entity 3457 | PurchaseCommon Stock | 1,000 | $28.48 | $28,479.00 |
DisclosureSEC source: 0001415889-22-002283 · form4-03032022_040307.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,467 Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 22:48 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 168.8397 | $28.38 | $4,791.67 |
DisclosureSEC source: 0001179110-22-000130 · edgar.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,458.0764 Underlying: Common Stock · 168.8397 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.38 on December 31, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 166.7248 | $28.74 | $4,791.67 |
DisclosureSEC source: 0001179110-21-010540 · edgar.xml · derivative · entry 2 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,289.2367 Underlying: Common Stock · 166.7248 shares Expires not disclosed F2 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F3 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021. F3 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021. F2 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 22:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 7,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-010540 · edgar.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,467 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 19:48 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | PurchaseCommon Stock | 1,000 | $28.32 | $28,317.60 |
DisclosureSEC source: 0001127602-21-029098 · form4.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,676 F1 · shares: The shares were purchased by the reporting person in a single block trade at $28.3176. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 20:28 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 111.5164 | $32.88 | $3,666.66 |
DisclosureSEC source: 0001179110-21-009766 · edgar.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122.5119 Underlying: Common Stock · 111.5164 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.88 on October 29, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:20 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 114.9784 | $31.89 | $3,666.66 |
DisclosureSEC source: 0001179110-21-009151 · edgar.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010.9955 Underlying: Common Stock · 114.9784 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.89 on September 30, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:23 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 109.846 | $33.38 | $3,666.66 |
DisclosureSEC source: 0001235110-21-000028 · edgar.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 896.0171 Underlying: Common Stock · 109.846 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $33.38 on August 31, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 20:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 100.5391 | $36.37 | $3,656.61 |
DisclosureSEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 7 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786.1711 Underlying: Common Stock · 100.5391 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F9 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F9 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 19:11 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 1,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-022494 · form4.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,122 Underlying: Common Stock · 1,014 shares Expires not disclosed F1 · derivative.exercise_price: Units convert into shares of common stock on a 1 for 1 basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · shares: These units represent an adjustment to the 2021 annual grant in accordance with a change in Omega's Director compensation. The reporting person has elected their grant be taken as Deferred Stock Units. The units are restricted as to transfer and sale until Omega's 2022 Annual Meeting of Shareholders (the "Vesting Date"). F3 · derivative.exercise_date: These units are restricted as to sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F4 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| June 30, 2021 Filed Aug 3, 2021 20:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 105.6979 | $34.69 | $3,666.66 |
DisclosureSEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 6 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 685.632 Underlying: Common Stock · 105.6979 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F8 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F8 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 21:59 UTC | Extended Stay America, Inc. STAY · Entity 16197 | SalePaired Shares | 1,500 | $18.75 | $28,125.00 |
DisclosureSEC source: 0000895345-21-000589 · form4.xml · nonDerivative · entry 2 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · price: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F3 · ownership.nature: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 21:59 UTC | Extended Stay America, Inc. STAY · Entity 16197 | SalePaired Shares | 41,001 | $18.75 | $768,768.75 |
DisclosureSEC source: 0000895345-21-000589 · form4.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · price: All Paired Shares held directly or indirectly by the reporting person were disposed upon completion of the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, effective June 16, 2021. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 17:32 UTC | ESH Hospitality, Inc. NONE · Entity 16193 | Disposition to issuerPaired Shares | 1,500 | $18.75 | $28,125.00 |
DisclosureSEC source: 0000895345-21-000606 · form4.xml · nonDerivative · entry 2 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F2 · kind: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F2 · price: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F3 · ownership.nature: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 17:32 UTC | ESH Hospitality, Inc. NONE · Entity 16193 | Disposition to issuerPaired Shares | 41,001 | $18.75 | $768,768.75 |
DisclosureSEC source: 0000895345-21-000606 · form4.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. This Form 4 is being filed in connection with the merger ("Merger") of a wholly-owned subsidiary of Eagle Parent Holdings L.P. ("Eagle") with and into the Issuer, pursuant to the terms of the certain Agreement and Plan of Merger, dated as of March 14, 2021 (the "Merger Agreement"), between the Issuer and Eagle. The Merger closed on June 16, 2021. F2 · kind: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. F2 · price: Each Paired Share held directly or indirectly by the reporting person at the effective time of the Merger was disposed of for $18.75 in cash, pursuant to the terms of the Merger Agreement. This price does not include the special dividend of $1.75 per Paired Share that the reporting person has the right to receive in connection with the consummation of the Merger. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 17:34 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantDeferred Stock Units · Derivative | 6,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-019483 · form4.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,108 Underlying: Common Stock · 6,108 shares Expires not disclosed F1 · derivative.exercise_price: Units convert into shares of common stock on a 1 for 1 basis. If the participant so elects, dividends will also be converted into Deferred Stock Units. F2 · shares: These units represent the annual grant of restricted stock elected to be taken as Deferred Stock Units by the reporting person. The units are restricted as to transfer and sale until Omega's 2022 Annual Meeting of Shareholders (the "Vesting Date"). F3 · derivative.exercise_date: These units are restricted as to sale and transfer until the Vesting Date. The units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. F4 · derivative.expiration_date: These units will be converted into shares of common stock upon separation from service, death, disability, or certain specified events, all as defined in such plan. Read SEC document |
| May 28, 2021 Filed Aug 3, 2021 20:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 101.9083 | $35.98 | $3,666.66 |
DisclosureSEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 5 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579.9341 Underlying: Common Stock · 101.9083 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F7 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F7 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| April 30, 2021 Filed Aug 3, 2021 20:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 115.631 | $31.71 | $3,666.66 |
DisclosureSEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 4 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478.0258 Underlying: Common Stock · 115.631 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F6 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F6 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 31, 2021 Filed Aug 3, 2021 20:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 124.5046 | $29.45 | $3,666.66 |
DisclosureSEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 3 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362.3948 Underlying: Common Stock · 124.5046 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F5 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F5 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| February 26, 2021 Filed Aug 3, 2021 20:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 111.5843 | $32.86 | $3,666.66 |
DisclosureSEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 2 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237.8902 Underlying: Common Stock · 111.5843 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| January 29, 2021 Filed Aug 3, 2021 20:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 126.3059 | $29.03 | $3,666.66 |
DisclosureSEC source: 0000950138-21-000400 · edgar.xml · derivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126.3059 Underlying: Common Stock · 126.3059 shares Expires not disclosed F1 · security: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021. F1 · derivative.exercise_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 22:50 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000499 · edgar.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,160 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| June 11, 2020 Filed Jun 15, 2020 18:16 UTC | OMEGA HEALTHCARE INVESTORS INC OHI · Entity 3362 | GrantCommon Stock | 4,597 | $32.63 | $150,000.11 |
DisclosureSEC source: 0001127602-20-019547 · form4.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,676 F1 · shares: Represents Director compensation via the annual grant of restricted stock that will vest on the date of the Company's 2021 Annual Meeting of shareholders, which is approximately one year from grant date. Read SEC document |
| May 28, 2020 Filed May 29, 2020 16:17 UTC | ESH Hospitality, Inc. NONE · Entity 16193 | GrantPaired Shares | 10,918 | $0.00 | $0.00 |
DisclosureSEC source: 0000895345-20-000666 · form4.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,001 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · kind: The reported transaction is an award of Restricted Stock Units in respect of Paired Shares. A Form 4 reflecting the transaction in Paired Shares by the reporting person shown on this Form 4 has been concurrently filed with respect to Extended Stay America, Inc. as issuer. Of the 10,918 Paired Shares acquired in the reported transaction, 5,459 were granted to the reporting person under the Amended and Restated Extended Stay America, Inc. Long-Term Incentive Plan and 5,459 were granted to the reporting person under the Amended and Restated ESH Hospitality, Inc. Long-Term Incentive Plan. Subject to the reporting person's continued service as a director of the issuer through the vesting date, these Restricted Stock Units are scheduled to vest in full on May 28, 2021. F3 · kind: Vested Restricted Stock Units will be settled in Paired Shares on the September 15th next following the vesting date (or, in any year when the 15th of September falls on a non-business day, the business day immediately prior to such date). Read SEC document |
| May 28, 2020 Filed May 29, 2020 16:11 UTC | Extended Stay America, Inc. STAY · Entity 16197 | GrantPaired Shares | 10,918 | $0.00 | $0.00 |
DisclosureSEC source: 0000895345-20-000663 · form4.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,001 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · kind: The reported transaction is an award of Restricted Stock Units in respect of Paired Shares. A Form 4 reflecting the transaction in Paired Shares by the reporting person shown on this Form 4 has been concurrently filed with respect to ESH Hospitality, Inc. as issuer. Of the 10,918 Paired Shares acquired in the reported transaction, 5,459 were granted to the reporting person under the Amended and Restated Extended Stay America, Inc. Long-Term Incentive Plan and 5,459 were granted to the reporting person under the Amended and Restated ESH Hospitality, Inc. Long-Term Incentive Plan. Subject to the reporting person's continued service as a director of the issuer through the vesting date, these Restricted Stock Units are scheduled to vest in full on May 28, 2021. F3 · kind: Vested Restricted Stock Units will be settled in Paired Shares on the September 15th next following the vesting date (or, in any year when the 15th of September falls on a non-business day, the business day immediately prior to such date). Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 09:10 UTC | ESH Hospitality, Inc. NONE · Entity 16193 | PurchasePaired Shares | 1,500 | $9.95 | $14,925.00 |
DisclosureSEC source: 0000895345-20-000295 · form4.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,500 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · ownership.nature: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary. Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 09:11 UTC | Extended Stay America, Inc. STAY · Entity 16197 | PurchasePaired Shares | 1,500 | $9.95 | $14,925.00 |
DisclosureSEC source: 0000895345-20-000296 · form4.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,500 F1 · security: Each Paired Share is comprised of one share of common stock, par value $0.01 per share, of Extended Stay America, Inc. and one share of Class B common stock, par value $0.01 per share, of ESH Hospitality, Inc., which shares are paired and traded as a single unit. F2 · ownership.nature: These Paired Shares are held through an individual retirement account for which the reporting person is a fiduciary. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 21:09 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 1,000 | $26.86 | $26,860.00 |
DisclosureSEC source: 0000950138-20-000138 · edgar.xml · nonDerivative · entry 1 Anand Kapila K · CIK 0001679166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,275 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.